Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United States

 

Interview: Walter Shekman, CEO, Dobrobut

Against the backdrop of the Russia-Ukraine war, HBI speaks to the CEO of the Ukrainian hospital group Dobrobut, Walter Shekman, to understand the day-to-day challenges it is facing, and how the private sector can assist the sector.

Babylon saga reaches end

Digital unicorn-turned-mouse Babylon Health has placed two of its UK divisions into administration and reportedly sold its clinical services business to US digital health firm eMed Healthcare.

Buy or bust for Babylon UK?

Digital health unicorn-turned-mouse Babylon could still have buyers for its UK business, despite its recent difficulties.

Interview – Ingeborg Oie, CFO and Chief Strategy Officer, Huma 

In this wide ranging interview we discuss the future of remote patient monitoring (RPM) software and government progress in ehealth. Through its RPM platform,  Huma claims to massively cut costs and improve outcomes for patients with chronic conditions.

FREE BLOG Emerging market providers make up half the Top 50

Half the top 50 listed health care service groups globally by market cap are now headquartered in emerging markets. What does that tell us about the sector internationally?  We publish the top 50 with detailed analysis in Deals and Insights.

Beleaguered Babylon searches for UK buyer, closes in the US

Under fire digital health company Babylon is shutting down its US operations and looking to sell its UK business. Plans to merge with Swiss digital neurotherapy company MindMaze and be taken private by creditors have collapsed and it is now on the brink of bankruptcy.

Eugin sale “imminent”

Germany-based healthcare conglomerate Fresenius’ restructuring plans seem to be gathering steam, as HBI hears the sale of its Spain-based fertility clinic Eugin is imminent. 

The fall of Babylon

Telehealth company Babylon will be merged with digital neurotherapy company MindMaze and taken private by its creditors. HBI catches up with two digital health experts to discuss what happened to Babylon and what the sorry saga means for the market.  

Find Us